PROTOCOL

«Research Protocol v2.0

Project: OmniLatent

Subtitle: Learning Generalizable, Robust, and Interpretable Multimodal Representations from Biomedical Data

Author: AIResearcher20

Status: Active Development

Version: 2.0

Last Updated: July 2026»

---

Table of Contents

1. Vision
2. Scientific Motivation
3. Problem Statement
4. Research Questions
5. Scientific Hypotheses
6. Project Objectives
7. Scope
8. Success Criteria

---

1. Vision

The rapid growth of biomedical data has transformed modern healthcare and life sciences. Large-scale initiatives such as The Cancer Genome Atlas (TCGA) provide heterogeneous patient information, including transcriptomic, genomic, and clinical measurements.

Despite these advances, most machine learning methods focus on solving individual prediction tasks rather than learning reusable representations that capture the underlying biological structure shared across different modalities.

OmniLatent aims to address this limitation by developing a general-purpose framework for multimodal biomedical representation learning.

Instead of optimizing for a single downstream task, the framework is designed to learn latent representations that are:

- biologically meaningful,
- clinically informative,
- transferable across diseases,
- robust to incomplete observations,
- interpretable by researchers.

The long-term vision of OmniLatent is to provide a reusable representation learning framework that can support multiple biomedical discovery tasks while remaining modular, reproducible, and extensible.

---

2. Scientific Motivation

Biomedical datasets are becoming increasingly multimodal.

Modern patient cohorts simultaneously contain:

- RNA sequencing
- Clinical information
- Somatic mutations
- DNA methylation
- Copy number variation
- Medical imaging
- Histopathology

However, these heterogeneous modalities are often analyzed independently or simply concatenated before model training.

Such approaches may fail to capture complementary biological information distributed across modalities.

Representation Learning offers an alternative paradigm.

Rather than learning a task-specific predictor, representation learning aims to discover compact latent variables that preserve meaningful biological variation while remaining useful across multiple downstream analyses.

OmniLatent is motivated by the hypothesis that high-quality multimodal representations can improve biological interpretation, patient stratification, and generalization across diseases.

---

3. Problem Statement

Current biomedical machine learning methods often suffer from one or more of the following limitations:

- reliance on a single data modality,
- limited biological interpretability,
- weak robustness to missing data,
- poor transferability across diseases,
- dependence on specific prediction tasks.

Consequently, there is a need for a general framework capable of learning reusable multimodal representations that preserve clinically and biologically relevant information.

This project addresses that challenge.

---

4. Research Questions

The project is organized around the following scientific questions.

RQ1

How can heterogeneous biomedical modalities be integrated into a unified latent representation?

---

RQ2

Does multimodal representation learning outperform unimodal representation learning?

---

RQ3

Does nonlinear representation learning outperform classical dimensionality reduction techniques such as PCA?

---

RQ4

Are learned latent representations biologically meaningful?

---

RQ5

Can a single representation support multiple downstream biomedical analyses?

---

RQ6

Can representations learned from one cancer type generalize to unseen cancer types?

---

RQ7

Which modality contributes most to the learned representation?

---

RQ8

How robust are learned representations when one or more modalities are missing or corrupted?

---

5. Scientific Hypotheses

The following hypotheses will be investigated.

H1

Multimodal representations outperform RNA-only representations.

---

H2

Deep nonlinear representations outperform PCA.

---

H3

The learned latent space preserves clinically meaningful biological organization.

---

H4

Representations learned from one cancer cohort transfer to unseen cancer cohorts without retraining the encoder.

---

H5

The learned representations remain informative even under incomplete multimodal inputs.

---

6. Project Objectives

The primary objectives of OmniLatent are:

- Develop a modular framework for multimodal representation learning.
- Learn biologically meaningful patient embeddings.
- Compare multimodal and unimodal representations.
- Evaluate representation quality across multiple biological tasks.
- Study robustness under incomplete biomedical data.
- Evaluate cross-cancer generalization.
- Promote reproducible biomedical AI research.

---

7. Scope

Included

- TCGA datasets
- RNA sequencing
- Clinical variables
- Somatic mutation data
- Deep representation learning
- Cross-cancer evaluation
- Biological interpretation
- Open-source implementation

Excluded (Version 1)

- Histopathology images
- Foundation models
- Federated learning
- Multi-omics beyond the selected modalities
- Transformer-based architectures

These topics are reserved for future versions of the framework.

---

8. Success Criteria

The project will be considered successful if:

- The proposed framework consistently outperforms PCA and RNA-only Autoencoder baselines.
- Learned embeddings demonstrate meaningful biological organization.
- The framework generalizes across multiple cancer cohorts.
- Results remain robust under missing-modality experiments.
- All experiments are fully reproducible.
- The repository reaches publication-ready quality.

- 9. Dataset Selection

Primary Development Cohort

The initial implementation of OmniLatent will be developed using the TCGA Breast Invasive Carcinoma (TCGA-BRCA) cohort.

BRCA is selected because:

- it is one of the largest TCGA cohorts,
- all required modalities are available,
- molecular subtype annotations exist,
- survival information is available,
- it is widely used in biomedical AI literature.

---

External Validation Cohorts

To evaluate representation generalization, additional cancer types will be included.

Current validation datasets:

- TCGA-LUAD
- TCGA-KIRC

Future extensions may include:

- TCGA-COAD
- TCGA-LIHC
- TCGA-HNSC

---

10. Data Modalities

Version 1 integrates three complementary biomedical modalities.

RNA Sequencing

High-dimensional transcriptomic measurements representing gene expression.

Purpose:

- capture cellular activity
- identify biological programs

---

Clinical Data

Patient metadata including:

- Age
- Gender
- Tumor Stage
- Survival
- Treatment information (when available)

Purpose:

- clinical interpretation
- downstream evaluation

---

Somatic Mutation Data

Binary mutation profiles describing genomic alterations.

Purpose:

- genomic characterization
- molecular heterogeneity

---

11. Experimental Design

The project consists of multiple complementary experiments.

Experiment 1

Comparison between PCA and OmniLatent.

Objective:

Determine whether nonlinear multimodal representations improve latent structure.

---

Experiment 2

RNA-only Autoencoder versus Multimodal Autoencoder.

Objective:

Measure the benefit of integrating multiple data modalities.

---

Experiment 3

Biological Interpretation.

Objective:

Evaluate whether latent space reflects:

- cancer subtype
- tumor stage
- mutation burden

---

Experiment 4

Survival Analysis.

Objective:

Determine whether latent representations preserve prognostic information.

---

Experiment 5

Cross-Cancer Generalization.

Training:

TCGA-BRCA

Testing:

- TCGA-LUAD
- TCGA-KIRC

Encoder weights remain frozen.

No retraining is performed.

---

Experiment 6

Robustness Evaluation.

Missing modality experiments.

---

Experiment 7

Noise Injection.

Evaluate representation stability under noisy inputs.

---

Experiment 8

Ablation Study.

Remove one modality at a time.

Measure performance degradation.

---

12. Model Development Strategy

OmniLatent is intentionally designed as a framework rather than a single model.

Version roadmap:

Version 1

Multimodal Autoencoder

↓

Version 2

Variational Autoencoder

↓

Version 3

Contrastive Representation Learning

↓

Version 4

Foundation Representation Learning

The evaluation pipeline remains unchanged while representation learning algorithms evolve.

---

13. Baseline Methods

The proposed framework will be compared against established baseline approaches.

Method| Purpose
PCA| Classical linear dimensionality reduction
RNA Autoencoder| Nonlinear single-modal baseline
MOFA+| Multimodal factor analysis baseline
OmniLatent| Proposed framework

Future comparisons may include:

- DeepCCA
- MOGONET

---

14. Evaluation Metrics

Representation Quality

- Silhouette Score
- Davies–Bouldin Index
- Calinski–Harabasz Index

---

Biological Evaluation

- Molecular subtype association
- Tumor stage association
- Mutation burden
- Clinical phenotype association

---

Survival Evaluation

- Kaplan–Meier analysis
- Log-rank test
- Concordance Index (C-index)

---

Visualization

- PCA
- UMAP
- Heatmaps
- Latent feature plots

---

15. Statistical Analysis Plan

To ensure scientific rigor:

- Multiple random seeds will be used.
- Results will be reported as Mean ± Standard Deviation.
- Statistical significance tests will be performed where appropriate.
- Confidence intervals will be reported when applicable.

---

16. Robustness Evaluation

The robustness of learned representations will be evaluated under challenging conditions.

Experiments include:

- Missing RNA modality
- Missing Clinical modality
- Missing Mutation modality
- Gaussian noise injection
- Random feature corruption

The objective is to determine whether the learned latent space remains informative despite incomplete or degraded input data

17. Cross-Cancer Generalization

One of the primary scientific goals of OmniLatent is to evaluate whether learned representations are transferable beyond a single cancer type.

Training is performed exclusively on the TCGA-BRCA cohort.

After training:

- the encoder weights are frozen,
- no additional optimization is performed,
- embeddings are generated directly for external cohorts.

Evaluation cohorts include:

- TCGA-LUAD
- TCGA-KIRC

Future work may extend this evaluation to additional TCGA cohorts.

Successful transfer would indicate that the learned latent space captures general biological patterns rather than cohort-specific characteristics.

---

18. Interpretability

Representation quality is not evaluated solely by numerical performance.

The biological meaning of the latent space will also be investigated.

Analyses include:

- latent feature importance,
- association with clinical variables,
- molecular subtype enrichment,
- mutation burden,
- visualization of latent dimensions,
- downstream biological interpretation.

Interpretability is considered a core objective rather than an optional analysis.

---

19. Reproducibility

OmniLatent is developed with reproducible research principles.

The following practices will be adopted throughout the project:

- fixed random seeds,
- configuration-based experiments,
- version-controlled source code,
- publicly available datasets,
- documented software environment,
- deterministic preprocessing whenever possible,
- complete experiment logging.

Each experiment will store:

- configuration,
- trained model,
- generated embeddings,
- evaluation metrics,
- figures,
- execution logs.

---

20. Repository Organization

The repository is organized to clearly separate data, models, experiments, documentation, and manuscript preparation.

OmniLatent/

configs/

data/
    raw/
    processed/
    metadata/

notebooks/

src/
    data/
    models/
    training/
    evaluation/
    visualization/
    utils/

results/

figures/

paper/

docs/

---

21. Milestones

The project is divided into sequential development phases.

Phase| Status
Research Design| ✅ Completed
Repository Setup| ✅ Completed
Data Acquisition| 🟡 In Progress
Data Preprocessing| ⚪ Planned
Baseline Models| ⚪ Planned
OmniLatent v1| ⚪ Planned
Evaluation| ⚪ Planned
Cross-Cancer Analysis| ⚪ Planned
Manuscript Preparation| ⚪ Planned

---

22. Expected Deliverables

At the completion of the project, the following deliverables are expected:

- Open-source GitHub repository
- Reproducible training pipeline
- Patient embedding dataset
- Evaluation framework
- Publication-quality figures
- Reproducible experiments
- Scientific manuscript

---

23. Potential Risks and Mitigation

Risk| Mitigation Strategy
Missing patient identifiers| Careful harmonization across modalities
High-dimensional RNA data| Feature selection and normalization
Limited generalization| Cross-cancer validation
Overfitting| Regularization and early stopping
Missing modalities| Robustness experiments

---

24. Ethical Considerations

The project exclusively uses publicly available, de-identified biomedical datasets.

No personally identifiable information (PII) will be collected or processed.

All analyses will follow the usage policies associated with the original data sources.

---

25. Future Directions

Future versions of OmniLatent may incorporate:

- Variational Autoencoders
- Contrastive Learning
- Self-Supervised Learning
- Graph Neural Networks
- Foundation Models
- DNA methylation
- Copy Number Variation
- Proteomics
- Histopathology
- Spatial Transcriptomics

The framework is intentionally designed to support future methodological extensions without major architectural changes.

---

Guiding Principles

The development of OmniLatent follows five guiding principles:

1. Scientific questions drive methodological choices.
2. Reproducibility is mandatory.
3. Interpretability is a primary objective.
4. Generalization is evaluated rather than assumed.
5. The framework should remain modular, extensible, and reusable.

---

Conclusion

OmniLatent is conceived as a research framework rather than a single deep learning model.

Its objective is to provide a robust, interpretable, and generalizable approach for multimodal biomedical representation learning while maintaining high standards of scientific rigor, software engineering, and reproducibility.

This protocol serves as the reference document for all future development and experimentation within the OmniLatent project.
